Pfizer Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (420)

Latest Posts

About This Stock More About This Stock
Battle Of The Dow 30 Pharmas — PFE Vs. MRK
Article By: Bespoke Investment Group
Monday, August 26, 2019 4:00 PM EDT
Pfizer and Merck have been the two pure pharmaceutical plays in the Dow Jones Industrial Average since PFE was added to the index in April 2004 (MRK was added in 1979).
In this article: MRK, PFE Also: MYL
Read
E Dividend Heavy Hitters: End-Of-Summer Edition
Article By: David Moadel
Monday, August 26, 2019 2:30 AM EDT
As the summer comes to an inglorious conclusion, beef up your portfolio with this sampling of dividend kings and aristocrats.
In this article: F, JPM, MO, PEP, PFE, T, ED, IRM
Read
The Big Pharma Takeover Of Medical Cannabis
Article By: Jeff Desjardins
Monday, August 12, 2019 3:12 PM EDT
Today’s infographic explores how and why the notorious Big Pharma are interested in the nascent cannabis industry.
In this article: JNJ, NVS, MMNFF, ACBFF, TLRY, GWPH, SNY, PFE, GSK, MRK, AZN, ABBV, NVO, LLY, INSY, MON
Read
Pfizer Slides As Analysts Move To Sidelines Following Mylan Deal Guidance Cut
Article By: The Fly
Tuesday, July 30, 2019 1:39 PM EDT
Shares of Pfizer are under pressure after both Morgan Stanley and Bank of America Merrill Lynch downgraded the stock to Neutral-equivalent ratings.
In this article: PFE Also: MYL
Read
Pfizer, Mylan Announce Agreement To Combine Mylan With Upjohn
Article By: The Fly
Monday, July 29, 2019 9:10 AM EDT
Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer's off-patent branded and generic established medicines business, creating a new global pharmaceutical company.
In this article: PFE, MYL
Read

PARTNER HEADLINES

Latest Tweets for $PFE

No tweets yet!

$PFE

Daily Stock Pick: Pfizer
David Reynolds 7/2/2019 10:39:55 PM

I think #pfizer is overvalued. $PFE

Exact Sciences: Poised For Further Growth
James Dean Samuels 11/22/2018 6:59:36 PM

Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS

1 to 2 of 2 comments